GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Upper GI Tract/Standardizing FLIP Interpretation

Standardizing FLIP Interpretation

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated November 1, 2025

Quick Answer

Standardizing FLIP (Functional Lumen Imaging Probe) interpretation is crucial for ensuring its reliability and utility in clinical practice, especially for diagnosing and managing esophageal motility disorders. FLIP is a diagnostic tool that uses impedance planimetry to measure the geometry and distensibility of the esophagogastric junction (EGJ) and other parts of the esophagus.


Standardizing FLIP (Functional Lumen Imaging Probe) interpretation is crucial for ensuring its reliability and utility in clinical practice, especially for diagnosing and managing esophageal motility disorders. FLIP is a diagnostic tool that uses impedance planimetry to measure the geometry and distensibility of the esophagogastric junction (EGJ) and other parts of the esophagus. It provides valuable insights into esophageal function by assessing parameters like the EGJ distensibility index (EGJ-DI), which can help identify motility disorders such as achalasia.

However, the paper highlights several challenges in standardizing FLIP interpretation. One major issue is the lack of calibration standards across different FLIP systems, which results in inconsistencies due to variations in catheter size, balloon compliance, and software versions. Without harmonized calibration protocols, data reproducibility is compromised, particularly in multicenter studies and artificial intelligence modeling efforts. Furthermore, FLIP is underutilized for longitudinal monitoring, limiting its potential as a tool to track treatment outcomes over time. The absence of clinical correlation between FLIP measurements and validated symptom scores, such as the Eckardt score or EAT-10, further complicates its interpretation.

The authors call for future consensus updates to focus on calibration protocols, predictive modeling, and longitudinal quantification to transform FLIP into a standardized biomarker for esophageal motility assessment. This would enhance its diagnostic accuracy and utility in clinical practice.

Related Q&A

Basal Crypt Dysplasia in Barrett's Esophagus: GUT | July 2026

Introduction: Barrett's esophagus (BE) is the principal precursor of esophageal adenocarcinoma. Early detection of neoplastic transformation is essential for preventing cancer progression. This review discusses basal crypt dysplasia (CD), an emerging histological entity that may...

High-Resolution Impedance Manometry after POEM: AJG | May 2026

Introduction: Assessing esophageal clearance after peroral endoscopic myotomy (POEM) is essential for evaluating treatment success in achalasia. Timed barium esophagram (TBE) is the current standard, but high-resolution impedance manometry (HRiM) may provide a radiation-free physiological...

Magnetic Sphincter Augmentation Provides Durable GERD Control : Ann Surg | Jun 2026

Introduction: Magnetic sphincter augmentation (MSA) has emerged as an effective surgical option for patients with gastroesophageal reflux disease (GERD) who continue to experience symptoms despite medical therapy. By augmenting lower esophageal sphincter function while preserving...

New Strategies Needed for Resistant H. pylori : Indian J Gastroenterol | Jun 2026

Introduction: Helicobacter pylori infection affects more than half of the global population and remains a major cause of peptic ulcer disease, gastric mucosal inflammation, and gastric cancer. Successful eradication is a cornerstone of gastrointestinal practice,...

Vonoprazan–Tetracycline Dual Therapy Simplifies H. pylori Rescue Treatment : Gastroenterology | June 2026

Introduction: Helicobacter pylori Infection eradication after prior treatment failure remains a major therapeutic challenge due to increasing antibiotic resistance, poor tolerability of multidrug regimens and declining adherence rates. Simplified rescue strategies with improved safety and...

H. pylori Eradication Reduces Cancer but Mortality Benefit Remains Fragile : Gastroenterology | June 2026

Introduction Helicobacter pylori Infection eradication is widely accepted as a key strategy for prevention of Gastric Cancer. Large meta-analyses have consistently shown reductions in gastric cancer incidence following eradication therapy, supporting global screening and treatment...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer